Ledger.Open graph →
SEC Form D · filed October 16, 2018

Mati Therapeutics Inc

Offering
$1.2M
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Christopher L. Muller · Foothill Ranch, CAExec · DirectorRobert L. Butchofsky Ii · Austin, TXExec · DirectorDeepank L. Utkhede · Surrey, British Columbia, CanadaExec · DirectorThomas W. Halloran · Braintree, MAExec · DirectorEric Rowinsky · Tel Aviv, L3Exec · DirectorCameron L. Nelson · Vancouver, British Columbia, CanadaExecYonatan C. Cheifetz · Palo Alto, CAExec · DirectorFiona Barrie · Camana Bay, Grand Cayman, Cayman IslandsExec · DirectorCameron L. Nelson · Austin, TXExecDeepank L. Utkhede · Surrey, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗